Dermata Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Dermata Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
DRMA | Dermata Therapeutics | -$20.40 | -$1.59 | — | — | $0.00 | — | — | — | 11/21/2025 | |
DRMA | Dermata Therapeutics | -$41.80 | — | -$1.66 | — | $0.00 | — | $0.00 | — | 08/13/2025 | |
DRMA | Dermata Therapeutics | -$70.50 | — | -$4.50 | — | $0.00 | — | $0.00 | — | 05/14/2025 | |
DRMA | Dermata Therapeutics | -$31.50 | — | -$9.20 | — | $0.00 | — | $0.00 | — | 03/17/2025 | |
DRMA | Dermata Therapeutics | -$80.90 | -$26.40 | -$20.40 | 22.73% | $0.00 | — | $0.00 | — | 11/13/2024 | |
DRMA | Dermata Therapeutics | -$94.30 | -$37.90 | -$41.80 | -10.29% | $0.00 | — | $0.00 | — | 08/07/2024 | |
DRMA | Dermata Therapeutics | -$340.50 | -$54.00 | -$70.50 | -30.56% | $0.00 | — | $0.00 | — | 05/15/2024 | |
DRMA | Dermata Therapeutics | -$288.00 | — | -$31.50 | — | $0.00 | — | $0.00 | — | 03/21/2024 | |
DRMA | Dermata Therapeutics | -$480.00 | -$94.50 | -$81.00 | 14.29% | $0.00 | — | $0.00 | — | 11/09/2023 | |
DRMA | Dermata Therapeutics | -$576.00 | -$138.00 | -$94.50 | 31.52% | $0.00 | — | $0.00 | — | 08/10/2023 | |
DRMA | Dermata Therapeutics | -$792.00 | -$397.50 | -$340.50 | 14.34% | $0.00 | — | $0.00 | — | 05/11/2023 | |
DRMA | Dermata Therapeutics | -$720.00 | -$480.00 | -$288.00 | 40.00% | $0.00 | — | $0.00 | — | 02/21/2023 | |
DRMA | Dermata Therapeutics | -$137.60 | -$528.00 | -$480.00 | 9.09% | $0.00 | — | $0.00 | — | 11/10/2022 | |
DRMA | Dermata Therapeutics | -$2.06K | -$768.00 | -$576.00 | 25.00% | $0.00 | — | $0.00 | — | 08/15/2022 | |
DRMA | Dermata Therapeutics | -$2.90K | -$1.68K | -$792.00 | 52.86% | $0.00 | — | $0.00 | — | 05/16/2022 | |
DRMA | Dermata Therapeutics | — | -$840.00 | -$720.00 | 14.29% | — | — | $0.00 | — | 03/28/2022 | |
DRMA | Dermata Therapeutics | -$744.00 | -$1.10K | -$2.06K | -86.96% | $0.00 | — | $0.00 | — | 11/15/2021 | |
DRMA | Dermata Therapeutics | -$1.03K | — | -$1.68K | — | $0.00 | — | $0.00 | — | 09/27/2021 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-20.40 | $-26.40 | 22.7 % |
| Q2 | 2024-08-07 | $-41.80 | $-37.90 | -10.3 % |
| Q1 | 2024-05-15 | $-70.50 | $-54.00 | -30.6 % |
| Q3 | 2023-11-09 | $-81.00 | $-94.50 | 14.3 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
Si prevede che Dermata Therapeutics (DRMA) fornisca risultati il novembre 21, 2025. Gli ultimi risultati sono stati pubblicati il agosto 13, 2025 per il Q2.
L'EPS effettivo era $-1.66, che mancato la stima di $0.00.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.